G. Wandeler

Discipline

Economies et finances (6) Psychologie (3) Sociologie (1) Démographie (1)

Type de document

Articles (35) Mémoires, Thèses et HDR (1) Recensions (1)

Co-auteur

Date

Source

Mot-clé

cohorte (26) Human beings (25) Swiss (24) Treatment (22) thérapie (21) Therapeutics (21) Patients (20) Patients (20) virus (18) Confidence (16) Ci (Chinese poetry) (15) Immunodeficiency (14) Population (14) infection (13) adulte (13) Risk (13) Persons (13) Infection (13) adulte (13) risque (12) Use (12) Sex (11) Population (11) Men (11) Impact (11) Older people (11) Risk factors (11) art (10) Art (10) Art (10)

Documents écrit par G. Wandeler (36) | parle de G. Wandeler (0)

Costs and acceptability of simplified monitoring in HIV-suppressed patients switching to dual therapy: the SIMPL'HIV open-label, factorial randomised controlled trial.
A. Marinosci et al. (15 avr. 2024)
Long-term quantitative hepatitis B surface antigen (HBsAg) trajectories in persons with and without HBsAg loss on tenofovir-containing antiretroviral therapy.
L. Begré et al.
Long-term trends in hepatitis C prevalence, treatment uptake and liver-related events in the Swiss HIV Cohort Study.
L. Baumann et al.
Association of a Polygenic Risk Score With Osteoporosis in People Living With HIV: The Swiss HIV Cohort Study.
J.M. Schwenke et al. (15 sept. 2023)
Impact of Integrase Inhibitors on Cardiovascular Disease Events in People With Human Immunodeficiency Virus Starting Antiretroviral Therapy.
B. Surial et al. (11 sept. 2023)
Comparison of five different risk scores to predict incident type 2 diabetes in the Swiss HIV cohort study.
F. Blondet et al. (1 mai 2023)
Female Genital Mutilation/Cutting in the Swiss HIV Cohort Study: A Cross-Sectional Study.
F. Mauri et al.
Risk Factors and Incidence of Sexually Transmitted Infections in the Swiss HIV Cohort Study.
D. Bosetti et al.
Low Risk of Failing Direct-Acting Antivirals in People With Human Immunodeficiency Virus/Hepatitis C Virus From Sub-Saharan Africa or Southeastern Asia: A European Cross-Sectional Study.
C. Isfordink et al.
An Approach to Quantifying the Interaction between Behavioral and Transmission Clusters.
K. Kusejko et al. (10 avr. 2022)
Medication Adherence Evaluated Through Electronic Monitors During the 2020 COVID-19 Pandemic Lockdown in Switzerland: A Longitudinal Analysis.
C. Bandiera et al. (2022)
Long-term trends of alanine aminotransferase levels among persons living with human immunodeficiency virus/hepatitis B virus with and without hepatitis delta coinfection.
L. Begré et al. (2022)
The Impact of Binge Drinking on Mortality and Liver Disease in the Swiss HIV Cohort Study.
B. Surial et al. (14 janv. 2021)
Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL'HIV trial.
D. Sculier et al.
Brief Report: Switching From TDF to TAF in HIV/HBV-Coinfected Individuals With Renal Dysfunction-A Prospective Cohort Study.
B. Surial et al. (1 oct. 2020)
Clusters of Sexual Behavior in Human Immunodeficiency Virus-positive Men Who Have Sex With Men Reveal Highly Dissimilar Time Trends.
K. Kusejko et al. (16 janv. 2020)
Corrigendum to: Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients.
F. Olearo et al.
Rates and predictors of switching to tenofovir alafenamide-containing ART in a nationwide cohort.
B. Surial et al. (10 oct. 2019)
Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients.
F. Olearo et al.
Impact of Direct-Acting Antivirals on the Burden of HCV Infection Among Persons Who Inject Drugs and Men Who Have Sex With Men in the Swiss HIV Cohort Study.
G. Wandeler et al.
Trends in HCV treatment uptake, efficacy and impact on liver fibrosis in the Swiss HIV Cohort Study.
C. Béguelin et al.
Assessing the danger of self-sustained HIV epidemics in heterosexuals by population based phylogenetic cluster analysis.
T. Turk et al. (12 sept. 2017)
The Presence of Human Immunodeficiency Virus-Associated Neurocognitive Disorders Is Associated With a Lower Adherence to Combined Antiretroviral Treatment.
S. Kamal et al. (2017)
Hepatitis C virus transmission among human immunodeficiency virus-infected men who have sex with men: Modeling the effect of behavioral and treatment interventions.
R.D. Kouyos et al.
Liver fibrosis in treatment-naïve HIV-infected and HIV/HBV co-infected patients: Zambia and Switzerland compared.
G. Wandeler et al.

next